Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience

K. Hotta, K. Matsuo, H. Ueoka, K. Kiura, M. Tabata, S. Harita, K. Gemba, T. Yonei, A. Bessho, M. Tanimoto

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience'. Together they form a unique fingerprint.

Medicine & Life Sciences